These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2129454)

  • 21. Infection-Related Acute Care Events among Patients with Glomerular Disease.
    Glenn DA; Henderson CD; O'Shaughnessy M; Hu Y; Bomback A; Gibson K; Greenbaum LA; Zee J; Mariani L; Falk R; Hogan S; Mottl A;
    Clin J Am Soc Nephrol; 2020 Dec; 15(12):1749-1761. PubMed ID: 33082200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell suppression in primary glomerular disease.
    Rood IM; Hofstra JM; Deegens JK; Wetzels JF
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):166-81. PubMed ID: 24602466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis.
    Cattran DC
    Clin Nephrol; 1991; 35 Suppl 1():S43-7. PubMed ID: 1860267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous immunoglobulins in the treatment of glomerulopathies].
    Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M
    G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
    Zietse R; Weimar W
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1749-53. PubMed ID: 1407123
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of the idiopathic nephrotic syndrome.
    Glassock RJ
    Contrib Nephrol; 1980; 23():158-80. PubMed ID: 7002448
    [No Abstract]   [Full Text] [Related]  

  • 27. Ciclosporin in idiopathic nephrotic syndrome of children.
    Brodehl J; Hoyer PF
    Am J Nephrol; 1989; 9 Suppl 1():61-4. PubMed ID: 2923148
    [No Abstract]   [Full Text] [Related]  

  • 28. [Focal glomerular sclerosis].
    Belovezhdov M; Neshev Kh
    Vutr Boles; 1977; 16(4):14-8. PubMed ID: 335660
    [No Abstract]   [Full Text] [Related]  

  • 29. Pefloxacin as first-line treatment in nephrotic syndrome.
    Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
    Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advances in the treatment of adult nephrotic syndrome].
    Yokoyama H; Asaka M; Yamaya H; Wada T
    Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
    Mason PD
    J R Coll Physicians Lond; 1997; 31(2):137-41. PubMed ID: 9131509
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive therapy in primary glomerulonephritis (pros).
    Ponticelli C; Banfi G; Imbasciati E; Tarantino A
    Contrib Nephrol; 1982; (34):33-54. PubMed ID: 6293765
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunotherapy of primary glomerulonephritis].
    Ritz E; Mickisch O
    Internist (Berl); 1989 Mar; 30(3):180-95. PubMed ID: 2654060
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of salivary and serum secretory IgA in IgA mesangial nephritis and primary glomerulonephritis.
    Rostoker G; Terzidis H; Petit-Phar M; Lang P; Weil B
    Adv Exp Med Biol; 1995; 371B():835-7. PubMed ID: 7502908
    [No Abstract]   [Full Text] [Related]  

  • 35. [A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group].
    Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):503-6. PubMed ID: 9283216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK; Wetzels JF
    Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin treatment of glomerular diseases.
    Radhakrishnan J; Halevy D
    Expert Opin Investig Drugs; 2000 May; 9(5):1053-63. PubMed ID: 11060727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary glomerulopathies in Lithuania: a retrospective analysis of renal biopsy cases (2000-2006)].
    Beitnaraite S; Kovaliūnas E; Laurinavicius A
    Medicina (Kaunas); 2007; 43 Suppl 1():6-10. PubMed ID: 17551269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C; Brosius FC; Palmieri J
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.